Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Norbert Graf

Showing results (231-240 of 318) with videos related to

Pageof 32
Sort By:
Blood|May 25, 2013
Randomized trial comparing liposomal daunorubicin with idarubicin as induction for pediatric acute myeloid leukemia: results from Study AML-BFM 2004Ursula Creutzig, Martin Zimmermann, Jean-Pierre Bourquin, et al.
Nature Reviews. Urology|May 3, 2019
Publisher Correction: The UMBRELLA SIOP-RTSG 2016 Wilms tumour pathology and molecular biology protocolGordan M Vujanić, Manfred Gessler, Ariadne H A G Ooms, et al.
Pediatric Blood & Cancer|October 28, 2017
Irinotecan for relapsed Wilms tumor in pediatric patients: SIOP experience and review of the literature-A report from the SIOP Renal Tumor Study GroupJanna A Hol, Marry M van den Heuvel-Eibrink, Norbert Graf, et al.
Frontiers in Digital Health|December 27, 2021
AquaScouts: ePROs Implemented as a Serious Game for Children With Cancer to Support Palliative CareStefan Hoffmann, Robert Schraut, Thomas Kröll, et al.
Pediatric Blood & Cancer|April 26, 2018
Evaluation of boost irradiation in patients with intermediate-risk stage III Wilms tumour with positive lymph nodes only: Results from the SIOP-WT-2001 RegistryRaquel Dávila Fajardo, Eva Oldenburger, Christian Rübe, et al.
The Lancet. Oncology|July 2, 2018
Relapse of Wilms' tumour and detection methods: a retrospective analysis of the 2001 Renal Tumour Study Group-International Society of Paediatric Oncology Wilms' tumour protocol databaseJesper Brok, Marta Lopez-Yurda, Harm V Tinteren, et al.
Nature Reviews. Urology|October 13, 2018
The UMBRELLA SIOP-RTSG 2016 Wilms tumour pathology and molecular biology protocolGordan M Vujanić, Manfred Gessler, Ariadne H A G Ooms, et al.
Journal of Neuro-Oncology|April 7, 2006
Treatment options in childhood pontine gliomasSabine Wagner, Monika Warmuth-Metz, Angela Emser, et al.
European Journal of Cancer (Oxford, England : 1990)|June 5, 2019
Evaluation of needle biopsy as a potential risk factor for local recurrence of Wilms tumour in the SIOP WT 2001 trialSabine Irtan, Harm Van Tinteren, Norbert Graf, et al.
Lancet (London, England)|July 13, 2015
Omission of doxorubicin from the treatment of stage II-III, intermediate-risk Wilms' tumour (SIOP WT 2001): an open-label, non-inferiority, randomised controlled trialKathy Pritchard-Jones, Christophe Bergeron, Beatriz de Camargo, et al.
Pageof 32

Showing results (231-240 of 318) with videos related to

Sort By:
Pageof 32
Blood|May 25, 2013
Randomized trial comparing liposomal daunorubicin with idarubicin as induction for pediatric acute myeloid leukemia: results from Study AML-BFM 2004Ursula Creutzig, Martin Zimmermann, Jean-Pierre Bourquin, et al.
Nature Reviews. Urology|May 3, 2019
Publisher Correction: The UMBRELLA SIOP-RTSG 2016 Wilms tumour pathology and molecular biology protocolGordan M Vujanić, Manfred Gessler, Ariadne H A G Ooms, et al.
Pediatric Blood & Cancer|October 28, 2017
Irinotecan for relapsed Wilms tumor in pediatric patients: SIOP experience and review of the literature-A report from the SIOP Renal Tumor Study GroupJanna A Hol, Marry M van den Heuvel-Eibrink, Norbert Graf, et al.
Frontiers in Digital Health|December 27, 2021
AquaScouts: ePROs Implemented as a Serious Game for Children With Cancer to Support Palliative CareStefan Hoffmann, Robert Schraut, Thomas Kröll, et al.
Pediatric Blood & Cancer|April 26, 2018
Evaluation of boost irradiation in patients with intermediate-risk stage III Wilms tumour with positive lymph nodes only: Results from the SIOP-WT-2001 RegistryRaquel Dávila Fajardo, Eva Oldenburger, Christian Rübe, et al.
The Lancet. Oncology|July 2, 2018
Relapse of Wilms' tumour and detection methods: a retrospective analysis of the 2001 Renal Tumour Study Group-International Society of Paediatric Oncology Wilms' tumour protocol databaseJesper Brok, Marta Lopez-Yurda, Harm V Tinteren, et al.
Nature Reviews. Urology|October 13, 2018
The UMBRELLA SIOP-RTSG 2016 Wilms tumour pathology and molecular biology protocolGordan M Vujanić, Manfred Gessler, Ariadne H A G Ooms, et al.
Journal of Neuro-Oncology|April 7, 2006
Treatment options in childhood pontine gliomasSabine Wagner, Monika Warmuth-Metz, Angela Emser, et al.
European Journal of Cancer (Oxford, England : 1990)|June 5, 2019
Evaluation of needle biopsy as a potential risk factor for local recurrence of Wilms tumour in the SIOP WT 2001 trialSabine Irtan, Harm Van Tinteren, Norbert Graf, et al.
Lancet (London, England)|July 13, 2015
Omission of doxorubicin from the treatment of stage II-III, intermediate-risk Wilms' tumour (SIOP WT 2001): an open-label, non-inferiority, randomised controlled trialKathy Pritchard-Jones, Christophe Bergeron, Beatriz de Camargo, et al.
Pageof 32